Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
CANCER:
Melanoma
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
‹
Solid Tumor (16911
)
Ocular Melanoma (111
)
Uveal Melanoma (106
)
Cutaneous Melanoma (86
)
Mucosal Melanoma (33
)
Solid Tumor (16911
)
Ocular Melanoma (111
)
Uveal Melanoma (106
)
Cutaneous Melanoma (86
)
Mucosal Melanoma (33
)
›
Associations
(1043)
News
Trials
Search handles
@ADesaiMD
@AJacomeMD
@APassaroMD
@AaronGoodman33
@AdnanNagrial
@AlbigesL
@AndresFCardonaZ
@AnkitmanglaMD
@ArndtVogel
@BallenDF
@BeckiLee
@BenjaminBesseMD
@Bhosale26Bharat
@BizarMd
@BlessieNelson
@BraunMDPhD
@BrendonStilesMD
@CathyEngMD
@CharuAggarwalMD
@ChenyuLinMD
@DanChenMDPhD
@DavidSteensma
@DocMCotant
@DoyenJrme1
@DrBetofMDPhD
@DrBonillaOnc
@DrChoueiri
@DrCraigGedye
@DrDrAprilRose
@DrEzraCohen
@DrFelipeAdes
@DrHealeyBird
@DrJNaidoo
@DrMarietteLabo
@DrSapnaPatel
@DrSteveMartin
@DrVijayPatil11
@DrYukselUrun
@Dr_Ivanoncologo
@Dr_JJ_Berenguer
@Dr_RShatsky
@Dr_R_Kurzrock
@DrewMoghanaki
@EladSharonMD
@EvanHallMD
@FAndreMD
@FordePatrick
@FunchainMD
@GABOUALFA
@GRecondoMD
@GUONCGarciaJA
@GeneCollector
@GeorgeSledge51
@GlopesMd
@GorphePhilippe
@HCCvPDAC
@HTawbi_MD
@HadidiSamer
@HeManJespersen
@HeadNeckMD
@IbrahimSahinMD1
@JTrentMDPhD
@JWHarbourMD
@JYangMDPhD
@JavleMilind
@JeffGershenwald
@JoaquinJCabrera
@JulienMazieres
@LesinskiLab
@MPostow
@M_Tagliamento
@Melanoma_doctor
@Mi_onc
@Mike_Oertel_MD
@MunizThiago
@MyriamChalabi
@NDeVitoMD
@NagiSaghir
@NicoleKuderer
@NimaSharifiMD
@ODayMD
@OlofssonBagge
@OmidHamidMD
@OncHahn
@OncoloJo
@PAscierto
@PGrivasMDPhD
@PTarantinoMD
@PatelOncology
@PatrickHwuMD
@RahulBanerjeeMD
@RandySweisMD
@RenoHemonc
@RonenStoff
@SalemGIOncDoc
@ShaalanBeg
@SilviaMosoiu
@StephenVLiu
@SuyogCancer
@SyedAAhmad5
@SyedMAhmedMDPhD
@TJH0828
@TarekHaykal1
@TeresaSAmaral
@TiansterZhang
@UmutDisel
@VPrasadMDMPH
@VivekSubbiah
@ad1600
@ahmadalhader
@akeithstewart
@alexshoushtari
@anu_iris
@barrosonco
@binayshah
@bmassutis
@boutrosand
@bpiperdi
@bpshah79
@cancerassassin1
@davidhenrymd
@dawood_findakly
@deeptibehl1
@doctorC369
@dr_yakupergun
@drgandara
@drkiwicj
@drkomanduri
@gary_lyman
@hematologo
@ilyassahinMD
@ivanpantic1980
@jamecancerdoc
@jasonlukemd
@josemarciofigu1
@joshuamammen
@jrgralow
@jryckman3
@jsoriamd
@jtmoyers
@landau_lab
@leitaomd
@lynn_schuchter
@marklewismd
@michaelwangmd
@montypal
@mtmdphd
@n8pennell
@navstruck
@neerajaiims
@ninashah33
@oncologician
@pashtoonkasi
@pawel_sobczuk
@rbryanbell
@rschilsky
@rutkowskip1972
@saadvikdr
@schoffski
@sdanson1
@sejadiMD
@sueyom
@ta_sussman
@tmprowell
@todrashish
@weldeiry
Search handles
@ADesaiMD
@AJacomeMD
@APassaroMD
@AaronGoodman33
@AdnanNagrial
@AlbigesL
@AndresFCardonaZ
@AnkitmanglaMD
@ArndtVogel
@BallenDF
@BeckiLee
@BenjaminBesseMD
@Bhosale26Bharat
@BizarMd
@BlessieNelson
@BraunMDPhD
@BrendonStilesMD
@CathyEngMD
@CharuAggarwalMD
@ChenyuLinMD
@DanChenMDPhD
@DavidSteensma
@DocMCotant
@DoyenJrme1
@DrBetofMDPhD
@DrBonillaOnc
@DrChoueiri
@DrCraigGedye
@DrDrAprilRose
@DrEzraCohen
@DrFelipeAdes
@DrHealeyBird
@DrJNaidoo
@DrMarietteLabo
@DrSapnaPatel
@DrSteveMartin
@DrVijayPatil11
@DrYukselUrun
@Dr_Ivanoncologo
@Dr_JJ_Berenguer
@Dr_RShatsky
@Dr_R_Kurzrock
@DrewMoghanaki
@EladSharonMD
@EvanHallMD
@FAndreMD
@FordePatrick
@FunchainMD
@GABOUALFA
@GRecondoMD
@GUONCGarciaJA
@GeneCollector
@GeorgeSledge51
@GlopesMd
@GorphePhilippe
@HCCvPDAC
@HTawbi_MD
@HadidiSamer
@HeManJespersen
@HeadNeckMD
@IbrahimSahinMD1
@JTrentMDPhD
@JWHarbourMD
@JYangMDPhD
@JavleMilind
@JeffGershenwald
@JoaquinJCabrera
@JulienMazieres
@LesinskiLab
@MPostow
@M_Tagliamento
@Melanoma_doctor
@Mi_onc
@Mike_Oertel_MD
@MunizThiago
@MyriamChalabi
@NDeVitoMD
@NagiSaghir
@NicoleKuderer
@NimaSharifiMD
@ODayMD
@OlofssonBagge
@OmidHamidMD
@OncHahn
@OncoloJo
@PAscierto
@PGrivasMDPhD
@PTarantinoMD
@PatelOncology
@PatrickHwuMD
@RahulBanerjeeMD
@RandySweisMD
@RenoHemonc
@RonenStoff
@SalemGIOncDoc
@ShaalanBeg
@SilviaMosoiu
@StephenVLiu
@SuyogCancer
@SyedAAhmad5
@SyedMAhmedMDPhD
@TJH0828
@TarekHaykal1
@TeresaSAmaral
@TiansterZhang
@UmutDisel
@VPrasadMDMPH
@VivekSubbiah
@ad1600
@ahmadalhader
@akeithstewart
@alexshoushtari
@anu_iris
@barrosonco
@binayshah
@bmassutis
@boutrosand
@bpiperdi
@bpshah79
@cancerassassin1
@davidhenrymd
@dawood_findakly
@deeptibehl1
@doctorC369
@dr_yakupergun
@drgandara
@drkiwicj
@drkomanduri
@gary_lyman
@hematologo
@ilyassahinMD
@ivanpantic1980
@jamecancerdoc
@jasonlukemd
@josemarciofigu1
@joshuamammen
@jrgralow
@jryckman3
@jsoriamd
@jtmoyers
@landau_lab
@leitaomd
@lynn_schuchter
@marklewismd
@michaelwangmd
@montypal
@mtmdphd
@n8pennell
@navstruck
@neerajaiims
@ninashah33
@oncologician
@pashtoonkasi
@pawel_sobczuk
@rbryanbell
@rschilsky
@rutkowskip1972
@saadvikdr
@schoffski
@sdanson1
@sejadiMD
@sueyom
@ta_sussman
@tmprowell
@todrashish
@weldeiry
Filter by
Latest
9ms
Hussein A. Tawbi, MD, PhD, and Allison Betof Warner, MD, PhD, discuss treatments for a patient with BRAF mutation–negative #melanoma. #melsm | @MDAndersonNews @StanfordCancer @DrBetofMDPhD https://t.co/iMqVhUSeET (@TargetedOnc)
9 months ago
Clinical
|
BRAF (B-raf proto-oncogene)
|
BRAF mutation
9ms
1. Lessons from Melanoma: Building on PD1 backbone w/ CTLA/LAG3 (FS Hodi, @wolchokj, @MPostow) 2. What’s new in IrAE mgmt? @DrJNaidoo @CardioOncology @kreynoldsMD 3. RCC Germline Genetics: Past, Present, Future (Linehan,@KidneyCancerDoc @pearldaily) 4. @kidneycan FallAdvocacy (@MikeSerzanMD)
9 months ago
IO biomarker
|
PD-1 (Programmed cell death 1) • LAG3 (Lymphocyte Activating 3)
9ms
Hot off the press 📢 Introduction of LAG-3 checkpoint blockade in melanoma beyond PD-1 and CTLA-4 @HTawbi_MD @MDAndersonNews (@FirasKreidieh)
9 months ago
Checkpoint inhibition • Checkpoint block
|
LAG3 (Lymphocyte Activating 3)
9ms
Here, @jasonlukemd shares insight into the final distant metastasis-free survival analysis of #KEYNOTE716 as presented at the @ASCO annual meeting. Learn more here: https://t.co/Nf8A1JbYCH #onctwitter #medtwitter #ASCO2023 #melanoma #pembrolizumab (@OncLearnNetwork)
9 months ago
Keytruda (pembrolizumab)
9ms
I caught up with world renowned researchers (& friends) @ProfGLongMIA and @HelenRizos who lead the amazing multidisciplinary team who did this to hear more about the incredible data that was discovered! @MelanomaAus @SydneyLHD @Sydney_Uni @CPC_usyd @Macquarie_Uni @syd_health (@ProfRScolyerMIA)
9 months ago
9ms
Amazing news, brilliant teamwork & extrapolation learning from Neoadjuvant immunotherapy pre & post surgery in high risk melanoma.Hoping you continue to feel well & that outcomes & prognosis continue to improve for you Richard,& all with GB with as few side effects as possible x (@kym83810679)
9 months ago
Clinical • Adverse events • Surgery • Post-surgery
9ms
We are continuing to highlight noteworthy research from #ASCO23! Next up, watch @OmidHamidMD, of @angelesclinic, discuss phase 1 findings with fianlimab plus cemiplimab in patients with advanced melanoma. @ASCO #melsm https://t.co/fSpDpEVMQQ (@OncLive)
9 months ago
Clinical • Metastases
|
Libtayo (cemiplimab-rwlc) • fianlimab (REGN3767)
9ms
Sorry I'm slow! - data on interstitial flow mechanics and lymphatic uptake would 💯 agree that lymphatic vessels accumulate EVs - see also @hps2002 - an interesting driving mech. of early lymphatic remodeling here - maybe why melanomas can spread so early and aggressively? (@theLundLab)
9 months ago
9ms
What's the latest in advanced #melanoma care? Get the latest evidence and insights from Drs. @jasonlukemd, @MeredithMcKean, & Kari Kendra in a new #MedEd activity: https://t.co/EO7en6a5BZ #OncTwitter #MedTwitter (@PeerView)
9 months ago
Metastases
9ms
As we continue to showcase exciting research from the 2023 ASCO Annual Meeting, watch @BrianGastmanMD, of @ClevelandClinic, discuss findings from a biomarker analysis of the CheckMate76K study in patients with stage IIB/C melanoma! @ASCO #ASCO23 #melsm https://t.co/Mg1dDPmIfX (@OncLive)
9 months ago
Clinical
9ms
I’m extremely happy to announce that I just received the George and Marie #Vergottis Fellowship!🥹 So excited and honored to be a part of the incredible @Boland_Lab and learn from @gmboland, the most amazing mentor ever! Exciting results in #melanoma #research coming soon🤩🤯🙌🏼📚 (@dedeilia)
9 months ago
9ms
Another great study by @HTawbi_MD and international team on role of immunotherapy as first line attempt against melanoma brain mets. While not all patients responded, always have the option of other local therapy options like radiosurgery and surgery #btsm @WeTrialshub (@DrAMansouri)
9 months ago
Clinical • Surgery
9ms
Dear Prof,you are an inspiration.A man of dedication,innovation, humility & courage🙏your years of research,& team advances of Rx melanoma can be extrapolated &lead to improved prognosis,quality of life, &life expectancy for you, & all who suffer this cruel disease Glioblastoma x (@kym83810679)
9 months ago
HEOR
9ms
Thanks Richard hope you well as now. I expect to read your next interesting melanoma papers (@urso_c)
9 months ago
9ms
It is hard to transfer the knowledge from melanoma to GBM. The data from melanoma is particularly tricky when folks think about cross-applying things in these two different cancers. (@DougCai)
9 months ago
9ms
Today @ProfGLongMIA and I talked to Ray Hadley about my #glioblastoma diagnosis and applying some of the lessons learnt in melanoma treatment to brain cancer. Watch and listen to our discussion via the link https://t.co/qjsFvWYJ3M @2GB873 @HadleyRayhadley (@ProfRScolyerMIA)
9 months ago
9ms
- CML imatinib (& other rarer dz) - EGFR, ALK, ROS, & others in NSCLC - HER2 in breast, gastric Ca - BRAF/MEK in melanoma, thyroid & others - FLT3, IDH in AML (tho trial designs variable) - PSMA in Lu-PSMA @Dr_R_Kurzrock (@Eddie_Cliff)
9 months ago
EGFR (Epidermal growth factor receptor) • HER-2 (Human epidermal growth factor receptor 2) • BRAF (B-raf proto-oncogene)
|
imatinib
9ms
Miss out on the @SocSurgOnc #SSO2023 Great Debate on Limb Infusion in #Melanoma? No worries, check out this summary of the debate coauthored by @DukeSurgery Dr. Georgia Beasley, @MoffittNews @jzager99, and @UTMBSurgery Dr. Doug Tyler. Link ⬇️ https://t.co/mSdAGirDni (@DukeSurgOnc)
9 months ago
Surgery
9ms
In this work, our findings showed that APRIL/TNFSF13 and its coordinated expression with CXCL10 and CXCL13 could serve as potential biomarkers for monitoring lymphoid aggregates/tumor-associated lymphoid structures (LA/TLS) status in melanoma patients. (https://t.co/dCM9QyMxUW) (@iayahbzour)
9 months ago
Clinical
|
CXCL10 (Chemokine (C-X-C motif) ligand 10) • CXCL13 (Chemokine (C-X-C motif) ligand 13) • TNFSF13 (TNF Superfamily Member 13)
|
CXCL10 expression
9ms
It has been an absolute pleasure and honor working with such an exceptional team on this project. Very grateful for the opportunity to work and learn from Dr. @KarapetLilit and @HMAbushukair. Looking forward to more exciting research endeavors together! #TLSkines #melanoma (@iayahbzour)
9 months ago
9ms
Proud to see our work on #TLSkines in #melanoma published! It has been an incredible educational experience working on this project with an exceptional team from @MoffittNews @UPMC @DanaFarber. Always a pleasure working and learning from Dr. @KarapetLilit @iayahbzour ! (@HMAbushukair)
9 months ago
9ms
My dads late stage melanoma shrank 30% in 6 months on Keytruda but unfortunately had done too much damage already to save his life. Early detection and treatment is the key (@Studio26151)
9 months ago
Keytruda (pembrolizumab)
9ms
I hope so professor! I don't have the knowledge you have but I am feeling a lot of hope lately with articles I am reading I keep praying the researchers are going to find a cure for glioblastoma and metastatic Ocular melanoma to liver! Hope! (@Abbeyandsmokey)
9 months ago
Metastases
9ms
My lab works on brain metastatic melanoma and glioblastoma. We are trying hard to find treatments that work for both. While we’ve had success in melanoma, glioblastoma has been very challenging. We now have preclinical models of all molecular subtypes and we will keep trying! (@HolmenSheri)
9 months ago
Preclinical • Metastases
9ms
As a stage 4 melanoma, five year survivor (5 and a half years to be exact) I’d say give immunotherapy a go (@WillLyall)
9 months ago
Metastases
9ms
Professor Scolyer, what is the plan of attack? Are you going to hit it with Ipi+nivo? 10 years ago in June of 2013 I was diagnosed stage 4 melanoma brain and lung mets. Part of checkmate 067, Nivo arm of trial after SRS cyberknife for 3 small brain mets. Best Wishes!!! (@EdWilli63968626)
9 months ago
Metastases
|
Opdivo (nivolumab) • Yervoy (ipilimumab)
9ms
Thank you! Always looking for hope uveal melanoma patients need it so much! (@Abbeyandsmokey)
9 months ago
Clinical
9ms
Today, #melanoma and #oncology experts gathered in Irving for the 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®: https://t.co/cRc8T1NxoO. Thank you all our co-chairs and faculty! @OmidHamidMD (@gotoPER)
9 months ago
9ms
I like @vgprieto14 's simplified summary from WHO chapter of melanoma molecular landscape. I screenshot it from his #USCAP23 talk as well. (@HoustonArsenal)
9 months ago
SKAP2 (Src Kinase Associated Phosphoprotein 2)
9ms
Don't miss this opportunity to gain valuable insights from a renowned expert in the field! 🌟 Register today: https://t.co/A48rLGLgw8 #MelanomaOncology #ExpertSpeaker #PrecisionOncology #PrecisionMedicine (@POETOncology)
9 months ago
9ms
📢 Thrilled to have Dr. @mcquadeMDLAc , MD, MS, MA, LAc, as one of our featured speakers at #POETCongress! 🗓️ Join us on Oct 12 & 13, 2023, at Bow Tower, Calgary, AB, for an inspiring talk. #MelanomaOncology #ExpertSpeaker #PrecisionOncology #PrecisionMedicine (@POETOncology)
9 months ago
9ms
In this article, Evan J. Lipson, MD, and participants discuss when they would use monotherapy or doublet therapy in metastatic #melanoma. #melsm | @evanlipson @hopkinskimmel @HopkinsMedicine https://t.co/DM2ZwS0NXD (@TargetedOnc)
9 months ago
Metastases
9ms
Dr. @gratitudemd continues the session on Melanoma. @uc_health @UCincyMedicine Updates on Hematology Oncology (@SyedAAhmad5)
9 months ago
9ms
🎁🍫🌸📚 Such a heartwarming gesture, Dr. Boland! It truly highlights the impact of your work and the strong bonds formed with your patients. The world needs more dedicated surgeons like you. Keep shining! #melanoma #cancer #cancerdocs @MGHCancerCenter @MGHSurgery (@chartnote)
9 months ago
Clinical • Surgery
9ms
Payer-led, evidence-based oncology pathways: similar tox & lower costs (~$17,600 less total health care cost) vs. off-pathway regimens. Melanoma had higher all-cause (aOR 1.68; P=.013) & tx-related hospitalization (aOR 1.64; P=.053). @DrDawnHershman ➡️ https://t.co/6tnwUko6SZ (@JCOOP_ASCO)
9 months ago
Clinical • Pricing • HEOR
9ms
Excellent presentation from @Antonio_arc95 discussing BRAF mutated metastatic melanoma in @SMEOMX resident session with @MKWongMDPhD . Learning valuable lessons from Dr. Wong and great cases with fellow residents from @incanMX and other institutions @incmnszmx @cmn20noviembre (@javiercboj)
9 months ago
Clinical • Metastases
|
BRAF (B-raf proto-oncogene)
|
BRAF mutation
9ms
Desde el MD Anderson Cancer Center, en Houston, TX, el doctor @MKWongMDPhD nos da una amena ponencia sobre Melanoma. Kudos, doctor 👍 (@manuab92)
9 months ago
9ms
@MKWongMDPhD Great melanoma morning! Thank you so much for the amazing talk, your experience is invaluable. (@fertzmh)
9 months ago
10ms
Melanoma. (@CerdaNiurka)
10 months ago
10ms
There is no correlation between RECIST response on the primary and Pathological Response in NEOAVAX study neoadjuvant setting in RCC- so what is the right endpoint ? Multi arm design is needed and learnings from melanoma colleagues @HaanenJohn @NKI_nl @myESMO (@AlbigesL)
10 months ago
Clinical
10ms
I agree, The other challenge is a less consistent signal of benefit of adjuvant IO therapy vs melanoma. what is goal of neoadjuvant tx? To increase chance of partial nephrectomy vs improve Long-term outcomes like RFS, OS? These studies may have different designs and endpoints. (@EvanHallMD)
10 months ago
Clinical
10ms
I would like to thank you for your life's work. My husband died of a melanoma, he received such care and compassion from his Oncology Team. I so wish that you get the miracle that he didn't, so many great new treatments, so much hope. (@abwillo)
10 months ago
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login